Taipei, Oct. 13 (CNA) Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan's domestic COVID-19 cases continue to surge
10/02/2022 07:48 PM - Politics
Taiwan's military recruitment pool shrinking due to low birth rate: report
10/02/2022 07:29 PM - Sports
Taiwanese shuttler Sung Shuo-yun advances to Canada Open final
10/02/2022 04:32 PM - Science & Tech
Taiwan donates computers to schools in Turkey
10/02/2022 02:55 PM - Society
Taiwan reports 43,307 new COVID-19 cases, 62 deaths
10/02/2022 02:23 PM